$OPGN
OPGEN INC Stock $opgn

$opgn Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000107997323000695 Filed on May 15, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$736.1K	$913.4K	$469.8K
YoY Change	-23.89%	94.45%	-43.4%
Cost Of Revenue	$714.4K	$592.4K	$322.6K
YoY Change	10.52%	83.65%	-51.13%
Gross Profit	$21.75K	$321.1K	$147.2K
YoY Change	-93.22%	118.13%	-13.42%
Gross Profit Margin	2.95%	35.15%	31.33%
Selling, General & Admin	$3.585M	$3.450M	$3.676M
YoY Change	8.52%	-6.16%	3.27%
% of Gross Profit	16487.5%	1074.56%	2497.79%
Research & Development	$1.389M	$1.813M	$2.316M
YoY Change	-38.92%	-21.74%	-17.56%
% of Gross Profit	6386.72%	564.63%	1573.78%
Depreciation & Amortization	$371.4K	$350.5K	$514.3K
YoY Change	-19.95%	-31.85%	-6.5%
% of Gross Profit	1708.16%	109.15%	349.39%
Operating Expenses	$4.974M	$5.263M	$5.993M
YoY Change	-10.82%	-12.18%	-5.92%
Operating Profit	-$5.156M	-$5.070M	-$5.846M
YoY Change	-2.2%	-13.27%	-5.71%
Interest Expense	$684.5K	$617.3K	-$958.0K
YoY Change	-12.23%	-164.44%	15.42%
% of Operating Profit
Other Income/Expense, Net	-$671.0K	-$666.5K	$0.00
YoY Change	18.08%		-100.0%
Pretax Income	-$5.827M	-$5.737M	-$6.804M
YoY Change	-0.22%	-15.68%	-54.18%
Income Tax
% Of Pretax Income
Net Earnings	-$5.827M	-$5.737M	-$6.804M
YoY Change	-0.22%	-15.68%	-54.19%
Net Earnings / Revenue	-791.61%	-628.02%	-1448.37%
Basic Earnings Per Share	-$0.93	-$1.25	-$2.93
Diluted Earnings Per Share	-$0.93	-$1.25	-$146.4K
COMMON SHARES
Basic Shares Outstanding	6.119M shares	5.496M shares	46.56M
Diluted Shares Outstanding	6.246M shares	4.577M shares	2.324M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.237M	$7.039M	$30.65M
YoY Change	-80.48%	-77.04%	-22.2%
Cash & Equivalents	$3.237M	$7.039M	$30.65M
Short-Term Investments
Other Short-Term Assets	$1.638M	$1.456M	$1.212M
YoY Change	-2.96%	20.1%	-17.54%
Inventory	$3.345M	$3.645M	$1.361M
Prepaid Expenses
Receivables	$619.6K	$666.8K	$265.9K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$7.229M	$10.74M	$33.49M
YoY Change	-64.23%	-67.93%	-21.69%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.850M	$3.667M	$5.479M
YoY Change	19.96%	-33.07%	-13.99%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$496.9K	$497.1K	$3.917M
YoY Change	12.59%	-87.31%	47.25%
Total Long-Term Assets	$15.21M	$15.77M	$30.77M
YoY Change	-46.83%	-48.74%	-5.01%
TOTAL ASSETS
Total Short-Term Assets	$7.229M	$10.74M	$33.49M
Total Long-Term Assets	$15.21M	$15.77M	$30.77M
Total Assets	$22.43M	$26.51M	$64.26M
YoY Change	-54.03%	-58.74%	-14.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$195.3K	$266.6K	$865.4K
YoY Change	-73.32%	-69.19%	-30.76%
Accrued Expenses	$1.043M	$1.436M	$3.726M
YoY Change	32.35%	-61.46%	-23.17%
Deferred Revenue	$27.28K	$46.00K
YoY Change
Short-Term Debt	$9.191M	$4.959M	$0.00
YoY Change	-15.58%
Long-Term Debt Due	$9.191M	$4.959M	$14.42M
YoY Change	-15.58%	-65.61%	2968.36%
Total Short-Term Liabilities	$12.42M	$8.636M	$19.01M
YoY Change	-13.74%	-54.58%	189.39%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$5.358M	$7.958M
YoY Change	-100.0%	-32.67%	-59.1%
Other Long-Term Liabilities	$126.7K	$129.2K	$3.117M
YoY Change	-3.29%	-95.85%	0.88%
Total Long-Term Liabilities	$126.7K	$129.2K	$11.08M
YoY Change	-3.29%	-98.83%	-50.89%
TOTAL LIABILITIES
Total Short-Term Liabilities	$12.42M	$8.636M	$19.01M
Total Long-Term Liabilities	$126.7K	$129.2K	$11.08M
Total Liabilities	$15.58M	$17.33M	$30.09M
YoY Change	-27.38%	-42.39%	3.33%
SHAREHOLDERS EQUITY
Retained Earnings	-$284.4M	-$278.6M
YoY Change	14.59%
Common Stock	$69.68K	$54.96K
YoY Change	-85.06%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$6.860M	$9.177M	$34.17M
YoY Change
Total Liabilities & Shareholders Equity	$22.43M	$26.51M	$64.26M
YoY Change	-54.03%	-58.74%	-14.5%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$5.827M	-$5.737M	-$6.804M
YoY Change	-0.22%	-15.68%	-54.19%
Depreciation, Depletion And Amortization	$371.4K	$350.5K	$514.3K
YoY Change	-19.95%	-31.85%	-6.5%
Cash From Operating Activities	-$4.753M	-$4.963M	-$5.041M
YoY Change	-28.63%	-1.56%	1.44%
INVESTING ACTIVITIES
Capital Expenditures	$367.3K	$330.4K	-$38.71K
YoY Change	-918.97%	-953.65%	-95.45%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$367.3K	-$330.4K	-$38.71K
YoY Change	718.97%	753.65%	-95.45%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.504M	$4.744M	-17.53K
YoY Change	-122.03%	-27160.18%	-100.05%
NET CHANGE
Cash From Operating Activities	-4.753M	-$4.963M	-5.041M
Cash From Investing Activities	-367.3K	-$330.4K	-38.71K
Cash From Financing Activities	1.504M	$4.744M	-17.53K
Net Change In Cash	-3.615M	-$399.2K	-5.098M
YoY Change	-73.29%	-92.17%	-119.24%
FREE CASH FLOW
Cash From Operating Activities	-$4.753M	-$4.963M	-$5.041M
Capital Expenditures	$367.3K	$330.4K	-$38.71K
Free Cash Flow	-$5.120M	-$5.293M	-$5.003M
YoY Change	-22.6%	5.8%	21.42%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-37367
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	OPGEN, INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	06-1614015
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	9717 Key West Avenue
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 100
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Rockville
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	MD
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	20850
CY2023Q1	dei	City Area Code CityAreaCode	(240)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	813-1260
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock
CY2023Q1	dei	Trading Symbol TradingSymbol	OPGN
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	6119449	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7039375	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7440030	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	666765	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	514372	usd
CY2023Q1	us-gaap	Other Inventory Net Of Reserves OtherInventoryNetOfReserves	1577762	usd
CY2022Q4	us-gaap	Other Inventory Net Of Reserves OtherInventoryNetOfReserves	1345137	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1455815	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1355949	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	10739717	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	10655488	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3666823	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3457531	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	2671	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	3500	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2139974	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1459413	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	7398333	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	7440974	usd
CY2023Q1	us-gaap	Inventory Noncurrent InventoryNoncurrent	2066795	usd
CY2022Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	2300614	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	497055	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	495629	usd
CY2023Q1	us-gaap	Assets Assets	26511368	usd
CY2022Q4	us-gaap	Assets Assets	25813149	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	266637	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	420821	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1424602	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1097654	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1436014	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1526204	usd
CY2023Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	46003	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	142061	usd
CY2023Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	4959417	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	7023901	usd
CY2023Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2803	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	3364	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	500994	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	377626	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	8636470	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	10591631	usd
CY2023Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	5358433	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	4850686	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	280	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3121433	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2566138	usd
CY2023Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	88635	usd
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	99498	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	129213	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	129368	usd
CY2023Q1	us-gaap	Liabilities Liabilities	17334184	usd
CY2022Q4	us-gaap	Liabilities Liabilities	18237601	usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5495546	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5495546	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2899911	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2899911	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	54955	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	28999	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	288326377	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	281167161	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-278561375	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-272824772	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-642773	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-795840	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	9177184	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	7575548	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	26511368	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	25813149	usd
CY2023Q1	us-gaap	Revenues Revenues	913444	usd
CY2022Q1	us-gaap	Revenues Revenues	469745	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	592378	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	291997	usd
CY2023Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	128306	usd
CY2022Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	30562	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1812831	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2316441	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2423953	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2625053	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1026087	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1051432	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	5983555	usd
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	6315485	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-5070111	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-5845740	usd
CY2023Q1	opgn	Interest And Other Income Expense InterestAndOtherIncomeExpense	30106	usd
CY2022Q1	opgn	Interest And Other Income Expense InterestAndOtherIncomeExpense	3121	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	617298	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	1269581	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-91994	usd
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	198740	usd
CY2023Q1	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	12694	usd
CY2022Q1	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	109744	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-666492	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-957976	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5736603	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6803716	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-5736603	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-6803716	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5736603	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-6803716	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.25
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.93
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4577269	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2324184	shares
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-5736603	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-6803716	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	153067	usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-483849	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-5583536	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7287565	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	41217080	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	241619	usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-483849	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-6803716	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	34171134	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	7575548	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	211122	usd
CY2023Q1	opgn	Public Offering Of Common Stock And Warrants Net Of Issuance Costs PublicOfferingOfCommonStockAndWarrantsNetOfIssuanceCosts	6974050	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	153067	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-5736603	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	9177184	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-5736603	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-6803716	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	350452	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	514269	usd
CY2023Q1	us-gaap	Accretion Expense AccretionExpense	456679	usd
CY2022Q1	us-gaap	Accretion Expense AccretionExpense	1091843	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	211122	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	241619	usd
CY2023Q1	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	256814	usd
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-12694	usd
CY2022Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-109744	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	142177	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-889810	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	195029	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	170028	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-3498	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-110332	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-157139	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-423955	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	100388	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-381830	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-97929	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4962618	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5041400	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	330446	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	38713	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-330446	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-38713	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	6974050	usd
CY2023Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	2229560	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	841	usd
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	17529	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4743649	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-17529	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	150186	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-413093	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-399229	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5510735	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7935659	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	36632186	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7536430	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	31121451	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	56320	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	1120	usd
CY2023Q1	opgn	Noncash Or Part Noncash Acquisition Rou Assets Acquired Through Operating Leases NoncashOrPartNoncashAcquisitionROUAssetsAcquiredThroughOperatingLeases	801321	usd
CY2023Q1	opgn	Exercise Price Of Common Warrants ExercisePriceOfCommonWarrants	2.65
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	268000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	opgn	Prefunded Warrants To Purchase PrefundedWarrantsToPurchase	215000	shares
CY2022Q4	opgn	Warrant Expiry Period WarrantExpiryPeriod	five and one-half
CY2022Q4	opgn	Increase In Fair Value From Warrant Modification IncreaseInFairValueFromWarrantModification	1800000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	495629	usd
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	37445	usd
CY2023Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	2351453	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	2596830	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	3644557	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	3645751	usd
CY2023Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1974030	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Use of estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In preparing financial statements in conformity with GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. In the accompanying unaudited condensed consolidated financial statements, estimates are used for, but not limited to, liquidity assumptions, revenue recognition, inducement expense related to warrant repricing, stock-based compensation, allowances for doubtful accounts and inventory obsolescence, discount rates used to discount unpaid lease payments to present values, valuation of derivative financial instruments measured at fair value on a recurring basis, deferred tax assets and liabilities and related valuation allowance, determining the fair value of assets acquired and liabilities assumed in business combinations, the estimated useful lives of long-lived assets, and the recoverability of long-lived assets. Actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2023Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	497055	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1694843	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7039375	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7440030	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	30653410	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	36080392	usd
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	497055	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	495629	usd
CY2022Q1	us-gaap	Restricted Cash RestrictedCash	468041	usd
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	551794	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7536430	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7935659	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	31121451	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	36632186	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2023Q1	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	1259859	usd
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	1011476	usd
CY2023Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	33245	usd
CY2023Q1	opgn	Currency Translation Adjustment CurrencyTranslationAdjustment	1871	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	46003	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	15518000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7869468	usd
CY2023Q1	opgn	Effects Of Foreign Exchange Rates EffectsOfForeignExchangeRates	250199	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	7398333	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7437206	usd
CY2022Q4	opgn	Effects Of Foreign Exchange Rates EffectsOfForeignExchangeRates	639820	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	7440974	usd
CY2022	opgn	Indefinitelived Intangible Impairment Charge IndefinitelivedIntangibleImpairmentCharge	5407699	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	186377	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	192025	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	564347	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	752463	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	752463	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	752463	usd
CY2023Q1	opgn	Finite Lived Intangible Assets Amortization Expense Year Six FiniteLivedIntangibleAssetsAmortizationExpenseYearSix	715644	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	3860953	usd
CY2023Q1	opgn	Finite Lived Intangible Assets Expected Amortization Expense FiniteLivedIntangibleAssetsExpectedAmortizationExpense	7398333	usd
CY2023Q1	opgn	Impairment Expense Of Goodwill ImpairmentExpenseOfGoodwill	6940549	usd
CY2023Q1	opgn	Reduction Of Research And Development Expense ReductionOfResearchAndDevelopmentExpense	133938	usd
CY2022Q1	opgn	Reduction Of Research And Development Expense ReductionOfResearchAndDevelopmentExpense	108465	usd
CY2023Q1	opgn	Grants Earned But Not Yet Received GrantsEarnedButNotYetReceived	544489	usd
CY2022	opgn	Grants Earned But Not Yet Received GrantsEarnedButNotYetReceived	401436	usd
CY2023Q1	opgn	Tax Benefit Percentage TaxBenefitPercentage	0.50	pure
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6700000	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1000000	shares
CY2023Q1	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	143506	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	913444	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	469745	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	913444	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	469745	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	142061	usd
CY2023Q1	us-gaap	Proceeds From Customers For Progress Payments ProceedsFromCustomersForProgressPayments	45577	usd
CY2022Q4	opgn	Increase In Fair Value From Warrant Modification IncreaseInFairValueFromWarrantModification	1800000	usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	99498	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	-12694	usd
CY2023Q1	opgn	Effect Of Foreign Exchange Rates1 EffectOfForeignExchangeRates1	1831	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	88635	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	6940549	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	5407699	usd
CY2023Q1	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	11631738	usd
CY2022Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	13489178	usd
CY2023Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	1313888	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	1614591	usd
CY2023Q1	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	10317850	usd
CY2022Q4	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	11874587	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	4959417	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	7023901	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	5358433	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	4850686	usd
CY2017Q2	us-gaap	Accounts Payable Interest Bearing Interest Rate AccountsPayableInterestBearingInterestRate	0.04	pure
CY2019Q2	us-gaap	Escrow Deposit Disbursements Related To Property Acquisition1 EscrowDepositDisbursementsRelatedToPropertyAcquisition1	5000000	eur
CY2020Q3	opgn	Percentage Of Participation Percentage Interest PercentageOfParticipationPercentageInterest	0.021	pure
CY2019Q2	us-gaap	Line Of Credit Facility Increase Decrease For Period Net LineOfCreditFacilityIncreaseDecreaseForPeriodNet	5000000	eur
CY2022Q2	us-gaap	Payments For Loans PaymentsForLoans	700000	eur
CY2023Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	617298	usd
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5495546	shares
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	85732	shares
CY2022	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	1030000.00	usd
CY2022	opgn	Net Proceeds From Issuance Of Common Stock NetProceedsFromIssuanceOfCommonStock	990000	usd
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	268000	shares
CY2022Q4	opgn	Prefunded Warrants In Shares PrefundedWarrantsInShares	215000	shares
CY2022Q4	opgn	Net Proceeds From Issuance Of Common Stock NetProceedsFromIssuanceOfCommonStock	3040000.00	usd
CY2023Q1	opgn	Exercise Price Of Common Warrants ExercisePriceOfCommonWarrants	2.65
CY2023Q1	opgn	Allocated Share Based Compensation Expense Benefit AllocatedShareBasedCompensationExpenseBenefit	211122	usd
CY2022Q1	opgn	Allocated Share Based Compensation Expense Benefit AllocatedShareBasedCompensationExpenseBenefit	241619	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2139974	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1459413	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	2671	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	3500	usd
CY2023Q1	opgn	Lease Right Of Use Asset LeaseRightOfUseAsset	2142645	usd
CY2022Q4	opgn	Lease Right Of Use Asset LeaseRightOfUseAsset	1462913	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	500994	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	377626	usd
CY2023Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2803	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	3364	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3121433	usd
CY2022Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	905	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2566138	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	280	usd
CY2023Q1	opgn	Lease Liability LeaseLiability	3625230	usd
CY2022Q4	opgn	Lease Liability LeaseLiability	2947408	usd
CY2023Q1	opgn	Operating And Finance Lease Liability Payments Remainder Of Fiscal Year OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	614034	usd
CY2023Q1	opgn	Operating And Finance Lease Liability Payments Due Year Two OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo	828063	usd
CY2023Q1	opgn	Operating And Finance Lease Liability Payments Due Year Three OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree	735009	usd
CY2023Q1	opgn	Operating And Finance Lease Liability Payments Due Year Four OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour	582753	usd
CY2023Q1	opgn	Operating And Finance Lease Liability Payments Due Year Five OperatingAndFinanceLeaseLiabilityPaymentsDueYearFive	593156	usd
CY2023Q1	opgn	Operating And Finance Lease Liability Payments Due After Year Five OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFive	1737689	usd
CY2023Q1	opgn	Operating And Finance Lease Liability Payments Due OperatingAndFinanceLeaseLiabilityPaymentsDue	5090704	usd
CY2023Q1	opgn	Operating And Finance Lease Liabilities Undiscounted Excess Amount OperatingAndFinanceLeaseLiabilitiesUndiscountedExcessAmount	1465474	usd
CY2023Q1	opgn	Operating And Finance Lease Liability OperatingAndFinanceLeaseLiability	3625230	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	138626	usd
CY2022Q1	us-gaap	Lease Cost LeaseCost	215530	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y8M12D
CY2023Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P0Y9M18D
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.096	pure
CY2023Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.01	pure
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	137797	usd
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	174914	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	841	usd
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	17529	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	801321	usd
CY2023Q2	opgn	Exercise Price Per Prefunded Warrant ExercisePricePerPrefundedWarrant	0.7785
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.25
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.93
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2324184	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4577269	shares
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures		usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures		usd
CY2022Q1	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge		usd
CY2022Q1	opgn	Noncash Or Part Noncash Acquisition Rou Assets Acquired Through Operating Leases NoncashOrPartNoncashAcquisitionROUAssetsAcquiredThroughOperatingLeases		usd
CY2023Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent		usd
CY2023Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability		usd
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001293818

Files In Submission

Name	View Source	Status
0001079973-23-000695-index-headers.html	Edgar Link	pending
0001079973-23-000695-index.html	Edgar Link	pending
0001079973-23-000695.txt	Edgar Link	pending
0001079973-23-000695-xbrl.zip	Edgar Link	pending
ex31x1.htm	Edgar Link	pending
ex31x2.htm	Edgar Link	pending
ex32x1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
opgn-20230331.htm	Edgar Link	pending
opgn-20230331.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
opgn-20230331_def.xml	Edgar Link	unprocessable
opgn-20230331_lab.xml	Edgar Link	unprocessable
opgn-20230331_pre.xml	Edgar Link	unprocessable
opgn-20230331_htm.xml	Edgar Link	completed
opgn-20230331_cal.xml	Edgar Link	unprocessable
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OPGN
OPGEN INC Stock $opgn

2023 Q2 Form 10-Q Financial Statement

#000107997323000695 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPGN OPGEN INC Stock $opgn

2023 Q2 Form 10-Q Financial Statement

#000107997323000695 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPGN
OPGEN INC Stock $opgn